Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
Launched by NEMOURS CHILDREN'S CLINIC · Sep 2, 2018
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a technique called umbilical cord milking (UCM) on newborns who are not vigorous at birth, meaning they need help to start breathing properly. The goal is to find out if UCM can help reduce the chances of serious brain injury, known as hypoxic-ischemic encephalopathy (HIE), or even death compared to the usual practice of clamping the umbilical cord early. This trial is particularly important for babies born in low-resource settings, where immediate care may be limited.
To be eligible for this study, babies must be non-vigorous and born between 35 and 42 weeks of pregnancy. However, babies with certain conditions, like major birth defects or those who are part of multiple births, cannot participate. Families whose babies join the trial can expect to have their child's cord milking assessed right after birth, and the outcomes will be closely monitored to see how it affects their health in the short and long term. This research aims to improve care for newborns in challenging situations and could lead to better treatment practices in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-vigorous neonates born between 35-42 weeks
- Exclusion Criteria:
- • Congenital malformation of CNS.
- • Chromosomal abnormalities.
- • Major congenital malformations.
- • Abruption/cutting through the placenta at delivery.
- • Umbilical cord knots or inadequate cord length.
- • Mono-chorionic twins or twins with no information on amnion/chorion.
- • Multiple gestation \>2 .
About Nemours Children's Clinic
Nemours Children's Clinic is a leading pediatric healthcare organization dedicated to enhancing the health and well-being of children through innovative clinical care, research, and education. As a prominent clinical trial sponsor, Nemours is committed to advancing pediatric medicine by conducting rigorous clinical trials that explore new treatments and therapies. The clinic's multidisciplinary team of experts collaborates closely with families and community partners to ensure that research initiatives are aligned with the unique needs of children. With a focus on safety, efficacy, and ethical standards, Nemours Children's Clinic aims to foster breakthroughs that will improve health outcomes for children and adolescents.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hubli, Karnataka, India
Belgaum, Karnataka, India
Nagpur, Maharashtra, India
Pune, Maharashtra, India
Nagpur, Ms, India
Nagpur, Ms, India
Nagpur, Ms, India
Wardha, Ms, India
Chandrapur, Ms, India
Jaipur, Rajasthan, India
Patients applied
Trial Officials
Zubair H Aghai, MD
Principal Investigator
Nemours Children's Clinic
Anup Katheria, MD
Principal Investigator
Sharp Mary Birch Hospital for Women & Newborns
Sangappa Dhaded, MD
Principal Investigator
KLE Academy of Higher Education and Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials